RXO Inc (NYSE: RXO) has seen a rise in its stock price by 2.85 in relation to its previous close of 16.16. However, the company has experienced a 20.78% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-11 that RXO, Inc. (NYSE:RXO ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Drew Wilkerson – Chief Executive Officer Jamie Harris – Chief Financial Officer Jared Weisfeld – Chief Strategy Officer Conference Call Participants Stephanie Moore – Jefferies Chris Wetherbee – Wells Fargo David Zulong – Barclays Jeff Kauffman – Vertical Research Partners Lucas Cervera – Truist Securities Ken Hoexter – Bank of America Ravi Shankar – Morgan Stanley Brian Ossenbeck – JPMorgan Bruce Chan – Stifel Jordan Alliger – Goldman Sachs Scott Schneeberger – Oppenheimer Operator Welcome to the RXO Q1 2025 earnings conference call and webcast. My name is Joelle and I will be your conference operator for today’s call.
Is It Worth Investing in RXO Inc (NYSE: RXO) Right Now?
Company’s 36-month beta value is 1.63.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 14 as “hold,” and 2 as “sell.”
The public float for RXO is 160.58M, and currently, short sellers hold a 4.35% ratio of that floaft. The average trading volume of RXO on May 14, 2025 was 1.73M shares.
RXO’s Market Performance
The stock of RXO Inc (RXO) has seen a 20.78% increase in the past week, with a 21.49% rise in the past month, and a -20.40% fall in the past quarter. The volatility ratio for the week is 7.76%, and the volatility levels for the past 30 days are at 5.93% for RXO. The simple moving average for the past 20 days is 19.11% for RXO’s stock, with a -31.16% simple moving average for the past 200 days.
Analysts’ Opinion of RXO
Truist, on the other hand, stated in their research note that they expect to see RXO reach a price target of $24. The rating they have provided for RXO stocks is “Buy” according to the report published on March 13th, 2025.
Deutsche Bank gave a rating of “Hold” to RXO, setting the target price at $19 in the report published on March 07th of the current year.
RXO Trading at 2.29% from the 50-Day Moving Average
After a stumble in the market that brought RXO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.36% of loss for the given period.
Volatility was left at 5.93%, however, over the last 30 days, the volatility rate increased by 7.76%, as shares surge +18.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.01% lower at present.
During the last 5 trading sessions, RXO rose by +20.78%, which changed the moving average for the period of 200-days by -45.42% in comparison to the 20-day moving average, which settled at $13.95. In addition, RXO Inc saw -30.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RXO starting from Szlosek Thomas A, who purchase 8,700 shares at the price of $14.41 back on May 09 ’25. After this action, Szlosek Thomas A now owns 8,700 shares of RXO Inc, valued at $125,354 using the latest closing price.
Nettles Michelle, the Director of RXO Inc, purchase 1,800 shares at $27.89 during a trade that took place back on Nov 12 ’24, which means that Nettles Michelle is holding 15,185 shares at $50,202 based on the most recent closing price.
Stock Fundamentals for RXO
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.16 for the gross margin
The net margin for RXO Inc stands at -0.06. The total capital return value is set at -0.03. Equity return is now at value -27.75, with -11.80 for asset returns.
Based on RXO Inc (RXO), the company’s capital structure generated 0.3 points at debt to capital in total, while cash flow to debt ratio is standing at -0.03. The debt to equity ratio resting at 0.43. The interest coverage ratio of the stock is -2.1.
Currently, EBITDA for the company is -187.0 million with net debt to EBITDA at 18.29. When we switch over and look at the enterprise to sales, we see a ratio of 0.67. The receivables turnover for the company is 4.41for trailing twelve months and the total asset turnover is 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.30.
Conclusion
In a nutshell, RXO Inc (RXO) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
